News

Weak energy conversion from the mitochondria in our cells can disrupt insulin release, fueling the symptoms associated with ...
Vertex is trimming its Rhode Island footprint on the back of a scrapped “cells plus device” program in diabetes, leaving 125 ...
Scientists at Tohoku University Graduate School of Medicine have identified colonic inflammation as a previously unrecognised ...
Researchers receive funding for proof-of-principle experiments investigating potential of cell replacement therapies for ...
The procedure is used exclusively for patients with Type 1 diabetes. It is not considered a treatment for Type 2 diabetes, ...